AR246310A1 - Procedimiento para la preparacion de la cadena alfa- del receptor de la interleucina 5 humana, o partes del mismo, secuencia del adn, vector y celula hospedante. - Google Patents

Procedimiento para la preparacion de la cadena alfa- del receptor de la interleucina 5 humana, o partes del mismo, secuencia del adn, vector y celula hospedante.

Info

Publication number
AR246310A1
AR246310A1 AR91321501A AR32150191A AR246310A1 AR 246310 A1 AR246310 A1 AR 246310A1 AR 91321501 A AR91321501 A AR 91321501A AR 32150191 A AR32150191 A AR 32150191A AR 246310 A1 AR246310 A1 AR 246310A1
Authority
AR
Argentina
Prior art keywords
human
parts
alpha chain
vector
procedure
Prior art date
Application number
AR91321501A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of AR246310A1 publication Critical patent/AR246310A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE LA CADENA ALFA DEL RECEPTOR DE LA INTERLEUCINA 5 HUMANA O PARTES DEL MISMO, LAS CUALES SE UNEN TODAVIA A LA INTERLEUCINA 5 HUMANA, QUE COMPRENDE EL CULTIVO DE UNA CELULA HOSPEDADORA TRANSFORMADA CON UN VECTOR DE EXPRESION QUE TIENE UNA SECUENCIA DE ADN QUE CODIFICA LA CADENA ALFA DEL RECEPTOR DE LA INTERLEUCINA 5 HUMANA O PARTES DEL MISMO LAS CUALES PARTES SE UNEN TODAVIA A LA INTERLEUCINA 5 HUMANA.
AR91321501A 1990-12-27 1991-12-23 Procedimiento para la preparacion de la cadena alfa- del receptor de la interleucina 5 humana, o partes del mismo, secuencia del adn, vector y celula hospedante. AR246310A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90811030 1990-12-27
EP91810327 1991-04-30

Publications (1)

Publication Number Publication Date
AR246310A1 true AR246310A1 (es) 1994-07-29

Family

ID=26127858

Family Applications (1)

Application Number Title Priority Date Filing Date
AR91321501A AR246310A1 (es) 1990-12-27 1991-12-23 Procedimiento para la preparacion de la cadena alfa- del receptor de la interleucina 5 humana, o partes del mismo, secuencia del adn, vector y celula hospedante.

Country Status (16)

Country Link
EP (1) EP0492214A3 (es)
JP (1) JP2554418B2 (es)
KR (1) KR920012440A (es)
AR (1) AR246310A1 (es)
AU (1) AU647560B2 (es)
CA (1) CA2058003A1 (es)
FI (1) FI916067A (es)
HU (1) HUT59725A (es)
IE (1) IE914548A1 (es)
IL (1) IL100470A0 (es)
MX (1) MX9102767A (es)
NO (1) NO915084L (es)
NZ (1) NZ241094A (es)
PT (1) PT99929A (es)
TW (1) TW280833B (es)
YU (1) YU199691A (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453491A (en) * 1990-09-11 1995-09-26 Kiyoshi Takatsu Murine interleukin-5 receptor
US5856097A (en) 1992-03-04 1999-01-05 The Regents Of The University Of California Comparative genomic hybridization (CGH)
US5654276A (en) * 1995-06-07 1997-08-05 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US5668110A (en) * 1995-06-07 1997-09-16 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US5677280A (en) * 1995-06-07 1997-10-14 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
US5683983A (en) * 1995-06-07 1997-11-04 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
ES2233974T3 (es) * 1995-09-11 2005-06-16 Kyowa Hakko Kogyo Co., Ltd. Anticuerpo contra la cadena alfa del receptor de la interleucina 5 humana.
US7049424B2 (en) 1996-07-15 2006-05-23 The Regents Of The University Of California Genes from the 20Q13 amplicon and their uses
US7455964B1 (en) 1996-07-15 2008-11-25 The Hospital For Sick Children Genes from the 20q13 amplicon and their uses
WO1997026332A1 (en) * 1996-01-17 1997-07-24 Schering Corporation Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin 5 antagonists
US5861279A (en) * 1996-01-17 1999-01-19 Schering Corporation Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin 5 antagonists
FR2783326B1 (fr) * 1998-09-10 2000-12-01 Immunotech Sa Procede de detection ou de quantification des basophiles et des eosinophiles
US7109299B1 (en) 1999-12-16 2006-09-19 Affymax, Inc. Peptides and compounds that bind to the IL-5 receptor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453491A (en) * 1990-09-11 1995-09-26 Kiyoshi Takatsu Murine interleukin-5 receptor

Also Published As

Publication number Publication date
JP2554418B2 (ja) 1996-11-13
AU647560B2 (en) 1994-03-24
EP0492214A2 (en) 1992-07-01
IE914548A1 (en) 1992-07-01
NO915084D0 (no) 1991-12-23
FI916067A0 (fi) 1991-12-20
JPH0678772A (ja) 1994-03-22
PT99929A (pt) 1993-01-29
NZ241094A (en) 1993-07-27
KR920012440A (ko) 1992-07-27
NO915084L (no) 1992-06-29
YU199691A (sh) 1994-06-24
FI916067A (fi) 1992-06-28
CA2058003A1 (en) 1992-06-28
EP0492214A3 (en) 1992-09-09
MX9102767A (es) 1992-06-30
HUT59725A (en) 1992-06-29
AU8998591A (en) 1992-10-15
HU913961D0 (en) 1992-02-28
IL100470A0 (en) 1992-09-06
TW280833B (es) 1996-07-11

Similar Documents

Publication Publication Date Title
AR241314A1 (es) Aislado de adn, vector en base en dicho aislado cultivo de celulas tratadas con dicho vector y preparacion de factor viii humano funcional.
AR246310A1 (es) Procedimiento para la preparacion de la cadena alfa- del receptor de la interleucina 5 humana, o partes del mismo, secuencia del adn, vector y celula hospedante.
FI946004A (fi) Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio
ES2109228T3 (es) Anticuerpos monoclonales mejorados contra el receptor de las celulas t alfa/beta humano, su produccion y uso.
ES2054638T3 (es) Gen codificante de los factores humanos de estimulacion colonial.
MX9203379A (es) Proteinas producidas por los linfocitos humanos, secuencia de adn que codifica para estas proteinas y composiciones farmaceuticas que las contienen.
ATE188486T1 (de) Modifizierte polypeptide mit erhoehter biologischer aktivitaet
ES2077666T3 (es) Proteina de union a fibronectina y su preparacion.
DK0538300T3 (da) O-Glycosyleret IFN-alfa
DK463586A (da) Fsh
ES2145451T3 (es) Secuencia de dna y proteina de cancer de mamas codificada especifica para mamas.
MX6339E (es) Metodo para elaborar dentro de un huesped bacteriano y excretar a traves de la membrana de la celula huesped,una proteina o un polipeptido seleccionados
EA199800946A1 (ru) Концентрированный препарат антител
DK163683D0 (da) Fremstilling af funktionelle humane urokinaseproteiner, dna-sekvens, der koder for et protein omfattende den enzymatiske del af human urokinase, replicerbart udtrykkelsesmedium, der kan udtrykkedna-sekvensen og mikroorganisme eller cellekultur transformeret med mediet
MX9202815A (es) Codificacion del polideoxirribonucleotido, plasmida y procedimiento para preparar un clono que contiene plasmida.
AR246765A1 (es) Novedosos genes y secuencias de adn del factor i del crecimiento del tipo de la preproinsulina humana.
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
ES2103733T3 (es) Procedimiento para combatir el piojo de los peces.
ES2146214T3 (es) Vacunas para actinobacillus pleuropneumoniae.
ES2091816T3 (es) Anticuerpos monoclonales del factor estimulador de colonias de macrofagos (m-csf) que reconocen un epitope conformacional neutralizante.
MX9203138A (es) Dominio de enlace cd2-de antigeno 3 (lfa-3) asociado con funcion linfositos.
DK403789D0 (da) Et nyt antibiotikum, mersacidin, dets fremstilling og anvendelse som laegemiddel
DK0625157T3 (da) Blodplade-GPIIIaP1A1- og -P1A2-epitoper og fremstilling og anvendelse deraf
DE69120390T2 (de) Kollagen-bindendes protein sowie dessen herstellung
ES2118720T3 (es) Produccion y utilizacion de agentes antihelminticos e inmunogenos protectores.